Health Condition 1: C148- Malignant neoplasm of overlappingsites of lip, oral cavity and pharynx
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Intervention3: Nil: Nil
Intervention4: NIL: NIL
Control Intervention1: NIL: NIL
Sponsors
TRAC
Eligibility
Inclusion criteria
Inclusion criteria: 1 Cancers of oral cavity, Carcinoma of unknown primary, oropharynx, larynx and hypopharynx who have received RT to unilateral or bilateral neck with or without concurrent Chemotherapy 2. Received RT dose to neck greater than 50GY 3. Patients treated with IMRT technique 4. Post RT at least 3 yr
Exclusion criteria
Exclusion criteria: 1. Not received RT to neck 2. Those not treated with IMRT 3. Nasopharyngeal cancer 4. Less than 3yr from treatment completion. 5. T1-T2 glottis cancer 6. Received re-irradiation 7. Metastatic disease at presentation 8. Recurrent disease at the time of evaluation for CAS 7. Metastatic disease at presentation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of moderate and severe long-term RT induced CAS and corelation with RT dose in patients of head neck cancers who received RT to neckTimepoint: Post Radiation 3 years | — |
Secondary
| Measure | Time frame |
|---|---|
| NILTimepoint: NIL | — |
Countries
India
Contacts
Public ContactDr Vishal Chavan
Tata Memorial Hospital, Mumbai
Outcome results
None listed